Julie Litz
- Oncology top 5%
- Lung Cancer Research Studies 2
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 2
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 9
- Ubiquitin and proteasome pathways 3
- Glycosylation and Glycoproteins Research 2
- Protein Kinase Regulation and GTPase Signaling 2
- Gastroenterology top 10%
-
- Cancer Mechanisms and Therapy 3
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Geoffrey W. KrystalElisabeth BuchdungerSittisak HonsawekFrancesco HofmannSarah J. ParsonsCarlos García-EcheverríaPaula M. HauckConstance M. Ely
- Cited by
- OncologyHematologyMolecular Biology
- Journals
- Journal of Biological Chemistry (1 paper)The Journal of Cell Biology (1 paper)The Journal of Physical Chemistry B (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Julie Litz
19 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Oncology 511
- Hematology 159
- Molecular Biology 885
- Gastroenterology 64
- Cancer Research 155
Countries citing papers authored by Julie Litz
This map shows the geographic impact of Julie Litz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Litz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Litz more than expected).
Fields of papers citing papers by Julie Litz
This network shows the impact of papers produced by Julie Litz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Litz. The network helps show where Julie Litz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Litz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2012 | 2 | |
| 3 | 2009 | 63 | |
| 4 | 2007 | 129 | |
| 5 | 2007 | 33 | |
| 6 | 2006 | 80 | |
| 7 | 2005 | 143 | |
| 8 | 2004 | 35 | |
| 9 | 2004 | 55 | |
| 10 | Flavopiridol potently induces small cell lung cancer apoptosis during S phase in a manner that involves early mitochondrial dysfunction. | 2003 | 23 |
| 11 | Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. | 2002 | 144 |
| 12 | Src family kinase activity is required for Kit-mediated mitogen-activated protein (MAP) kinase activation, however loss of functional retinoblastoma protein makes MAP kinase activation unnecessary for growth of small cell lung cancer cells. | 2000 | 36 |
| 13 | The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. | 2000 | 230 |
| 14 | 1999 | 37 | |
| 15 | Lck associates with and is activated by Kit in a small cell lung cancer cell line: inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1. | 1998 | 61 |
| 16 | Induction of apoptosis and inhibition of small cell lung cancer growth by the quinoxaline tyrphostins. | 1997 | 28 |
| 17 | 1992 | 108 | |
| 18 | 1991 | 55 | |
| 19 | 1990 | 137 | |
| 20 | 1989 | 24 |
About Julie Litz
Julie Litz is a scholar working on Molecular Biology, Cell Biology and Endocrinology, Diabetes and Metabolism, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Mechanisms and Therapy (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Lung Cancer Research Studies (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Oncology (511 citations), Hematology (159 citations) and Molecular Biology (885 citations). Julie Litz has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Geoffrey W. Krystal, Elisabeth Buchdunger, Sittisak Honsawek, Francesco Hofmann, Sarah J. Parsons, Carlos García-Echeverría, Paula M. Hauck, Constance M. Ely, Thomas W. Sturgill and Anthony Rossomando. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology and The Journal of Physical Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.